Transcriptomics

Dataset Information

0

A versatile CRISPR/Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells


ABSTRACT: CRISPR technologies have begun to revolutionize T cell therapies; however, conventional CRISPR/Cas9 genome-editing tools are limited in their safety, efficacy, and scope. To address these challenges, we developed MEGA (Multiplexed Effector Guide Arrays), a platform for programmable and scalable regulation of the T cell transcriptome using the RNA-guided, RNA-targeting activity of CRISPR/Cas13d. MEGA enables quantitative, reversible, and massively-multiplexed gene knockdown in primary human T cells without targeting or cutting genomic DNA. Applying MEGA to a model of CAR T cell exhaustion, we robustly suppressed inhibitory receptor upregulation and uncovered paired regulators of T cell function through combinatorial CRISPR screening. We additionally implemented druggable regulation of MEGA to control CAR activation in a receptor-independent manner. Lastly, MEGA enabled multiplexed disruption of immunoregulatory metabolic pathways to enhance CAR T cell fitness and anti-tumor activity in vitro and in vivo. MEGA offers a versatile synthetic toolkit for applications in cancer immunotherapy and beyond.

ORGANISM(S): Homo sapiens

PROVIDER: GSE246823 | GEO | 2023/11/06

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-10-29 | E-MTAB-11111 | biostudies-arrayexpress
2020-12-06 | GSE162720 | GEO
2022-06-09 | GSE203052 | GEO
2023-01-16 | GSE183256 | GEO
2022-01-21 | GSE135884 | GEO
2021-12-23 | GSE191329 | GEO
2022-11-15 | GSE214109 | GEO
2022-11-15 | GSE214108 | GEO
| PRJNA560405 | ENA
| PRJNA838356 | ENA